Sanofi
- Country
- 🇫🇷France
- Ownership
- Public
- Employees
- 87.9K
- Market Cap
- $141.3B
- Website
- http://www.sanofi.com
- Introduction
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
E3-Hormone Refractory Prostrate Cancer Taxotere Combination
- Conditions
- Prostate CancerMetastaticHormone Refractory
- First Posted Date
- 2007-07-10
- Last Posted Date
- 2016-10-07
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 86
- Registration Number
- NCT00498797
- Locations
- 🇸🇪
Research Site, Uppsala, Sweden
🇧🇷Research site, Rio de Janeiro, Brazil
Acceptability Lactoserum (Dermacyd Delicata - New Fragrance)
- Conditions
- Hygiene
- First Posted Date
- 2007-07-09
- Last Posted Date
- 2008-05-20
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 30
- Registration Number
- NCT00497783
- Locations
- 🇧🇷
Sanofi-aventis, São Paulo, Brazil
Topic Compatibility Lactoserum (Dermacyd Delicata - New Fragrance)
- Conditions
- Hygiene
- First Posted Date
- 2007-07-09
- Last Posted Date
- 2008-05-20
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 30
- Registration Number
- NCT00497692
- Locations
- 🇧🇷
Sanofi-aventis, São Paulo, Brazil
Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes Mellitus
- Conditions
- Sleep Initiation and Maintenance Disorders
- Interventions
- Drug: Placebo
- First Posted Date
- 2007-07-03
- Last Posted Date
- 2016-05-26
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 848
- Registration Number
- NCT00495885
- Locations
- 🇹🇷
Sanofi-Aventis Administrative Office, Istanbul, Turkey
MDR TB, Levofloxacin, Multi-Drug-Resistant Pulmonary Tuberculosis
- First Posted Date
- 2007-07-03
- Last Posted Date
- 2009-03-04
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 100
- Registration Number
- NCT00495339
- Locations
- 🇷🇺
Sanofi-Aventis, Moscow, Russian Federation
Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer
- Conditions
- Metastatic Prostate Cancer
- First Posted Date
- 2007-06-29
- Last Posted Date
- 2009-10-01
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 6
- Registration Number
- NCT00494338
- Locations
- 🇧🇷
Sanofi-Aventis, Sao Paulo, Brazil
Efficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation
- Conditions
- Atrial Fibrillation
- Interventions
- First Posted Date
- 2007-06-21
- Last Posted Date
- 2010-02-18
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 504
- Registration Number
- NCT00489736
- Locations
- 🇹🇷
Sanofi-Aventis Administrative Office, Istanbul, Turkey
Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis
- Conditions
- Multiple Sclerosis
- Interventions
- First Posted Date
- 2007-06-21
- Last Posted Date
- 2012-11-06
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 118
- Registration Number
- NCT00489489
- Locations
- 🇪🇸
Sanofi-Aventis Administrative Office, Barcelona, Spain
APIDRA Registration Study
- Conditions
- Diabetes Mellitus, Type 1
- First Posted Date
- 2007-06-21
- Last Posted Date
- 2009-03-16
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 45
- Registration Number
- NCT00489190
- Locations
- 🇰🇿
Sanofi-Aventis, Almaty, Kazakhstan
DOMME Dose Optimization Multicentric Mexican Evaluation
- First Posted Date
- 2007-06-20
- Last Posted Date
- 2010-09-13
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 371
- Registration Number
- NCT00488527
- Locations
- 🇲🇽
Sanofi-Aventis, Mexico, Mexico